| 摘要 |
<p>A mutated human alpha-synuclein having a lowered coagulation ability. This mutated human alpha-synuclein can inhibit the coagulation of wild type human alpha-synuclein, Ala53Thr mutated human alpha-synuclein or Ala50Pro mutated human alpha-synuclein and, therefore, is useful in discussions on the cause of Parkinson's disease, treatments for the diseases and researches aiming at developing gene therapy therefor. Moreover, a peptide having a human alpha-synuclein partial structure having the above-described amino acid mutation is provided.</p> |
